共 50 条
- [42] THE USE OF PERITONEAL-DIALYSIS FOR DELIVERY OF CHEMOTHERAPY TO INTRAPERITONEAL MALIGNANCIES [J]. RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 264 - 269
- [44] COMPLEMENT IN SERUM AND DIALYSATE IN CHILDREN ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1995, 15 (01): : 49 - 53
- [45] PHARMACOKINETICS OF INTRAPERITONEAL MOXALACTAM IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 493 - 493
- [48] EFFECTS OF INTRAPERITONEAL CYCLOOXYGENASE INHIBITION ON INFLAMMATORY MEDIATORS IN DIALYSATE AND PERITONEAL MEMBRANE-CHARACTERISTICS DURING PERITONITIS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1995, 126 (02): : 204 - 215
- [50] LONGITUDINAL-STUDY OF PROTEINS IN PLASMA AND DIALYSATE DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1990, 10 (04): : 257 - 261